About
Inhaled small molecule and combination drugs
Areas of Focus
Categories
Small Molecule PharmaceuticalTaiwan
Clinical Trials (20)
View allTotal Trials
20
As Lead Sponsor
18
As Collaborator
2
Total Enrollment
1,665
By Phase
NA: 11PHASE4: 1PHASE1: 6PHASE3: 1PHASE2: 1
By Status
COMPLETED: 14UNKNOWN: 3RECRUITING: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline20 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06990256Collaborator
Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers
NANot yet recruiting
80 participants
Started: Sep 1, 2025 · Completed: Dec 30, 2026
NCT06629636Collaborator
Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity.
NARecruiting
60 participants
Started: Aug 20, 2024 · Completed: Dec 31, 2026
NCT04912596Lead Sponsor
Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma
NARecruiting
148 participants
Started: Aug 15, 2022 · Completed: Jun 30, 2025
NCT05300087Lead Sponsor
Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90mcg Per Actuation in Healthy Volunteers Under Fasting Conditions
NACompleted
60 participants
Started: Feb 24, 2022 · Completed: Apr 26, 2022
NCT04823260Lead Sponsor
To Evaluate the Efficacy and Safety of NMN as an Anti-ageing Supplement in Middle Aged and Older (40-65 Years) Adults
NACompleted
90 participants
Started: May 25, 2021 · Completed: Sep 9, 2021
Locations (1)
Headquarters
Hsinchu, Taiwan
Map
Loading map...